Myriad Genetics (MYGN)

Add to Watchlists
Create an Alert
37.60 +0.92  +2.51% NASDAQ Oct 22, 8:00PM BATS Real time Currency in USD
View Full Chart
MYGN Price Chart
View All Events

MYGN Events

Date Type Description
11/04/2014 16:30 EDT Misc Q1 2015 Myriad Genetics Inc Earnings Conference Call
11/04/2014 Earnings Q1 2015 Myriad Genetics Inc Earnings Results
08/12/2014 16:30 EDT Misc Q4 2014 Myriad Genetics Inc Earnings Conference Call
08/12/2014 Earnings Q4 2014 Myriad Genetics Inc Earnings Results
05/06/2014 16:30 EDT Misc Q3 2014 Myriad Genetics Inc Earnings Conference Call
05/06/2014 Earnings Q3 2014 Myriad Genetics Inc Earnings Results
02/04/2014 16:30 EDT Misc Myriad Genetics, Inc. 2Q2014 Earning Conference Call
02/04/2014 Earnings Myriad Genetics, Inc. 2Q2014 Earning Result
12/12/2013 19:30 CST Misc Myriad Genetics Announces Upcoming Investor Event
12/05/2013 Misc AGM Event for Myriad Genetics, Inc.
View All Performance Charts

MYGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Myriad Genetics is up 53.09% over the last year vs S&P 500 Total Return up 12.11%, Quest Diagnostics up 7.16%, and Foundation Medicine down 29.16%.

Get Quote for

PDF Report for MYGN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download MYGN Pro Report PDF
Advertisement

Portfolio Strategies Featuring MYGN

Did Myriad Genetics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

MYGN Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Company Website: http://www.myriad.com
  • IR Website: http://investor.myriad.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: Utah
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: June 30, 2015
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: June 30, 2014
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.

MYGN Excel Add-In Codes

  • Name: =YCI("MYGN","name")
  • Description: =YCI("MYGN","description")
  • Sector: =YCI("MYGN","sector")
  • Industry: =YCI("MYGN","industry")
  • Est. Current Fiscal Year End: =YCI("MYGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.